Park Ha Biological Technology is trading 5.41% up at $3.31, with no clear company-specific catalyst identified for August 10, 2026. - The stock remains highly volatile after its 1-for-8 reverse stock split became effective on August 6. - Shares outstanding fell from approximately 18.76 million to 2.35 million. - Recent securities-litigation publicity remains a risk factor, but available coverage does not explicitly link it to today’s gain.